Clincosm LogoSign in Get a demo

non small cell lung cancer

Showing 1 - 25 of 663
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer Trial in France (Paclitaxel, Bevacizumab, Atezolizumab)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Amiens, France
  • +42 more
Mar 10, 2023

Advanced Cancer, Non Small Cell Lung Cancer Trial (Tepotinib, Pembrolizumab)

Not yet recruiting
  • Advanced Cancer
  • Non Small Cell Lung Cancer
  • (no location specified)
Mar 13, 2023

Genetic and Epigenetic Factors on Clinical Response and Toxicity

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Cisplatin injection
  • Cairo, Egypt
    Ain Shams University
Feb 16, 2023

Non Small Cell Lung Cancer Trial in Worldwide (IPH5201 + durvalumab + standard chemo)

Recruiting
  • Non Small Cell Lung Cancer
  • IPH5201 + durvalumab + standard chemotherapy
  • Tampa, Florida
  • +23 more
Feb 23, 2023

Melanoma, Non Small Cell Lung Cancer Trial in Moscow, Omsk, Saint Petersburg (BCD-201, Keytruda)

Active, not recruiting
  • Melanoma
  • Non Small Cell Lung Cancer
  • Moscow, Russian Federation
  • +2 more
Feb 13, 2023

Cancer Pain, Non Small Cell Lung Cancer, Bone Metastases Trial (Transcutaneous electrical acupoint stimulation, Sham

Not yet recruiting
  • Cancer Pain
  • +3 more
  • Transcutaneous electrical acupoint stimulation
  • +2 more
  • (no location specified)
Feb 17, 2023

Responsiveness in Oncology Patients Based on Host Response

Recruiting
  • Non Small Cell Lung Cancer
  • Healthy
  • blood, stool and tissue samples collection
  • Dallas, Texas
    Baylor Scott and White Research Institute
Feb 9, 2023

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,

Not yet recruiting
  • Advanced Cancer
  • +16 more
  • Fosifloxuridine Nafalbenamide
  • +3 more
  • Birmingham, United Kingdom
  • +3 more
Feb 1, 2023

Non Small Cell Lung Cancer Trial (Tislelizumab, Ociperlimab, LBL-007)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • (no location specified)
Jan 30, 2023

Determine Pro-Inflammatory Cytokine Kinetics During Immune

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Melanoma
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Jan 30, 2023

    Non Small Cell Lung Cancer Trial (Navtemadlin, Navtemadlin Placebo, Pembrolizumab)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • (no location specified)
    Jan 27, 2023

    Cancer, Solid Tumor, Colorectal Cancer Trial (biological, radiation, drug)

    Not yet recruiting
    • Cancer
    • +8 more
    • DK210 (EGFR)
    • +3 more
    • (no location specified)
    Jan 27, 2023

    Solid Tumor, Non Small Cell Lung Cancer, Melanoma Trial in Lafayette, Boston, Nashville (AB248, Pembrolizumab)

    Recruiting
    • Solid Tumor
    • +4 more
    • AB248
    • Pembrolizumab
    • Lafayette, Indiana
    • +2 more
    Jan 25, 2023

    Non Small Cell Lung Cancer, EGFR Gene Mutation, Immune Checkpoint Inhibitor Trial in Jerusalem (concomitant TTFields treatment

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • concomitant TTFields treatment device to standard of care EGFR positive NSCLC treatment
    • concomitant TTFields treatment device to standard of care anti PD-1 NSCLC treatment
    • Jerusalem, Israel
      Shaare Zedek Medical Center
    Jan 22, 2023

    Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

    Recruiting
    • Non Small Cell Lung Cancer
    • +16 more
    • Goodyear, Arizona
    • +10 more
    Jan 24, 2023

    Brain Metastases, Adult, Non Small Cell Lung Cancer, Breast Cancer Trial in Messina, Rome, Turin (Silibinin, Placebo)

    Recruiting
    • Brain Metastases, Adult
    • +2 more
    • Silibinin
    • Placebo
    • Messina, Italy
    • +4 more
    Jan 9, 2023

    Non Small Cell Lung Cancer, Metastatic NSCLC, Recurrent Non Small Cell Lung Cancer Trial (Pembrolizumab, GT103)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • (no location specified)
    Jan 12, 2023

    Non Small Cell Lung Cancer, Stage IV NSCLC, Recurrent Non Small Cell Lung Cancer Trial in Tampa (biological, drug, other)

    Recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • Tumor-infiltrating Lymphocytes (TIL)
    • +5 more
    • Tampa, Florida
      Moffitt Cancer Center
    Dec 28, 2022

    Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer Trial in United States

    Recruiting
    • Non Small Cell Lung Cancer
    • +11 more
    • Denver, Colorado
    • +3 more
    Jan 10, 2023

    Non Small Cell Lung Cancer Trial in Davis, Orlando, Columbus (ONC-392, Docetaxel)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Davis, California
    • +2 more
    Jan 5, 2023

    Non Small Cell Lung Cancer Trial in Pittsburgh (Fecal Microbiota Transplant (FMT), Pembrolizumab)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Dec 20, 2022

    Whole Blood From Active Non-Small Cell Lung Cancer Supplemental

    Recruiting
    • Non Small Cell Lung Cancer
    • Specimen sample
    • Waltham, Massachusetts
      Sanguine Biosciences
    Dec 28, 2022

    Non Small Cell Lung Cancer Trial (Ensartinib Hydrochloride)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Ensartinib Hydrochloride
    • (no location specified)
    Dec 15, 2022

    Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-small Cell Carcinoma Trial in United States (radiation,

    Recruiting
    • Non Small Cell Lung Cancer
    • +4 more
    • L-SABR
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Dec 20, 2022